A phase II study of S‑1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404)

Motoo Nomura,Takayuki Kii,Junji Kawada,Masashi Hirota,Takashi Ohta,Jin Matsuyama,Daisuke Sakai,Toshio Shimokawa,Yukinori Kurokawa,Hisato Kawakami,Toshimasa Tsujinaka,Taroh Satoh

Esophagus(2022)